| Vol. 12.29 – 27 July, 2023 |
| |
|
|
| Investigators identified protective functions of supersulphides in viral airway infections, in aged lungs and in chronic lung diseases, including COPD and idiopathic pulmonary fibrosis. [Nature Communications] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Researchers reported that RNA Methyltransferase 3-mediated m6A of GATA6 mRNA inhibited acute lung injury and the secretion of pro-inflammatory cytokine in airway epithelial cells. [American Journal Of Respiratory Cell And Molecular Biology] |
|
|
|
| Scientists identified Nolz-1/Znf503 as a mesenchymal lineage-specific transcriptional regulator that plays a key role in lung morphogenesis. Nolz-1 null mutation resulted in a severe hypoplasia phenotype, including a decreased proliferation of mesenchymal cells and aberrant differentiation of epithelial cells. [Development] |
|
|
|
| As extracellular matrix (ECM) was recognized as a vital component in directing cellular function and differentiation, investigators sought to derive hydrogels from decellularized human lung alveolar-enriched ECM to provide an ex vivo model to characterize the role of physiologically relevant ECM. [Scientific Reports] |
|
|
|
| Researchers retrieved sepsis-induced acute respiratory distress syndrome (ARDS) mRNA expression profile and identified 883 differentially expressed genes. A translational study on septic mice lungs by IHC staining revealed a hike in the expression of toll-like receptor 6 (TLR6) promoted by miR-34a. [3 Biotech] |
|
|
|
| Scientists found inhibitors of ataxia telangiectasia mutated and rad3 related (ATR) as the most effective agents for augmenting lurbinectedin efficacy. First-in-class ATR inhibitor berzosertib synergized with lurbinectedin in multiple SCLC cell lines, organoid, and in vivo models. [EMBO Molecular Medicine] |
|
|
|
| Investigators orchestrated the cellular and spatial architecture of multiple primary lung cancers (MPLCs) by combining single-cell RNA-sequencing and spatial transcriptomics. They identified a previously undescribed sub-population of epithelial cells termed as CLDN2+ alveolar type II which was enriched in MPLCs. [Cell Death & Disease] |
|
|
|
| To illuminate the molecular basis linking acquired mutation to tyrosine kinase inhibitor (TKI) resistance, affinity purification coupled mass spectrometry was adopted to dissect epidermal growth factor receptor interactome in TKI-sensitive and -resistant NSCLC cells. [Molecular & Cellular Proteomics] |
|
|
|
| Scientists employed a range of techniques, including qPCR and cell migration assays, in conjunction with online database analysis, to investigate the role of histone deacetylase inhibitors and histone deacetylase 2 (HDAC2)/YY1 in the process of lung adenocarcinoma migration. [Scientific Reports] |
|
|
|
|
| The authors explore the role of adenosine in fibrosis and evaluates the contribution of the different adenosine receptors to fibrogenesis. [Pharmacology & Therapeutics] |
|
|
|
| Investigators review the benefits and risks of inhaled corticosteroids use in COPD, drawing on evidence from recent randomized controlled trials and observational studies conducted in primary care. [NPJ Primary Care Respiratory Medicine] |
|
|
|
|
| Molecure S.A. has received of its Investigational New Drug Application from the US FDA to conduct Phase II clinical testing of OATD-01, the first-ever chitotriosidase 1 inhibitor with disease-modifying potential. The first pulmonary sarcoidosis patients in this Phase II study are scheduled to begin receiving treatment.. [Molecure S.A.] |
|
|
|
|
| August 12 – 13, 2023 Waterville Valley, New Hampshire, United States |
|
|
|
|
|
| Baylor College of Medicine – Sugar Land, Texas, United States |
|
|
|
| University of Alberta – Edmonton, Alberta, Canada |
|
|
|
| University of Kansas Medical Center – Kansa City, Kansas, United States |
|
|
|
| University College Dublin – Dublin, Ireland |
|
|
|
| NCI Center for Cancer Research – Bethesda, Maryland, United States |
|
|
|
|